Literature DB >> 7552632

The short-bowel syndrome.

J M Nightingale1.   

Abstract

Patients with a short bowel have usually had a bowel resection for Crohn's disease. Two types of short-bowel patient can be distinguished: those with a jejunostomy and those with their jejunum anastomosed to a functioning colon. Both types of patient have problems with macronutrient absorption, although those with a colon experience fewer problems because some energy from unabsorbed carbohydrate is salvaged in the colon. Patients with a jejunostomy have problems with large stomal losses of water, sodium and magnesium, whereas those with a jejuno-colic anastomosis rarely have problems with water and electrolyte absorption. Patients with a jejunostomy 100-200 cm from the duodeno-jejunal flexure ('absorbers') usually absorb more from the diet than they pass through the stoma and therefore require oral electrolyte or nutrient supplements. Those with a residual jejunal length of less than 100 cm usually secrete more from the stoma than they take in orally ('secretors') and therefore require long-term parenteral fluid or nutrient supplements. A high output resulting from a jejunostomy is treated by reducing the oral intake of hypotonic fluid, administering a sipped glucose-saline solution and, often, by giving drugs that reduce intestinal motility (most effective in absorbers) or gastrointestinal secretions (most effective in secretors). Gallstones are common both in short-bowel patients with and in those without a colon (45%), and calcium oxalate renal stones occur in the former (25%). However, it is now possible to provide adequate nutrition and fluid supplements for most patients with a short bowel, and the prospects for the rehabilitation of such patients are good.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7552632

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  3 in total

Review 1.  India's first successful intestinal transplant: the road traveled and the lessons learnt.

Authors:  A S Soin; R Mohanka; N Saraf; A Rastogi; S Goja; B Menon; V Vohra; S Saigal; R Sud; D Kumar; P Bhangui; S Ramachandra; P Singla; G Shetty; K Raghvendra; Kareem M Abu Elmagd
Journal:  Indian J Gastroenterol       Date:  2014-02-07

2.  Oxalate and calcium excretion in cystic fibrosis.

Authors:  M A Turner; D Goldwater; T J David
Journal:  Arch Dis Child       Date:  2000-09       Impact factor: 3.791

Review 3.  Dietary Management of Chronic Kidney Disease and Secondary Hyperoxaluria in Patients with Short Bowel Syndrome and Type 3 Intestinal Failure.

Authors:  Maciej Adler; Ewen C Millar; Kevin A Deans; Massimo Torreggiani; Francesca Moroni
Journal:  Nutrients       Date:  2022-04-14       Impact factor: 6.706

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.